TT-X (Teon Therapeutics)

N/A

Report date: 2023/10/26 10:03:20
NME

Base Information

Drug NameTT-X (Teon Therapeutics)
Drug Alias NameTT-X
ClassificationSmall molecules
Mechanisms of Action5'-nucleotidase inhibitors
Targets5'-nucleotidase
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTeon Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesTeon Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A